ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Drug Shortages in Otolaryngology

by Mary Beth Nierengarten • September 30, 2015

  • Tweet
  • Email
Print-Friendly Version

Antibiotics that otolaryngologists may recognize as having an impact on their practice, according to James C. Denneny III, MD, executive vice president and CEO of the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), could include ciprofloxacin, clindamycin, mupirocin ointment, and tetracycline antibiotics such as doxycycline.

You Might Also Like

  • National Drug Shortage Hits ENT Surgeries: Succinylcholine, propofol and tetracaine in limited supply
  • Rising Drug Costs Create Concern About Drug Diversions
  • Drug Selection Influences Drug-Induced Sleep Endoscopy Findings
  • When It Comes to Drug Development, What Do Our Dollars Buy?
Explore This Issue
October 2015
James C. Denneny III, MDThe FDA cannot require a company to make a drug, make more of a drug, or change a drug’s distribution, so more advanced warning and better strategies to communicate about potential shortages would be beneficial in terms of preparation. —James C. Denneny III, MD

Michael Setzen, MD, an otolaryngologist in private practice in Great Neck, New York, has seen a shortage in antibiotic topical medications over the past couple of months that has had an impact on the rhinology procedures he routinely performs on patients with chronic sinusitis. “When we do endoscopic sinus surgery, part of the reason we do the surgery is to make openings into the sinus to give us access to apply topical medications, particularly antibiotics,” he said. “Many pharmacies and companies have stopped making these topical antibiotics, so we need to turn to compound pharmacies that are difficult to find, and if we don’t have access to these pharmacies, then we’ll have to treat patients with steroids or saline sprays.”

Managing these patients over the long term is the challenge, he said, emphasizing that these patients still need the surgery but that long-term management is now more difficult without topical antibiotics. Outcomes may also not be as good in these patients, he said.

Along with antibiotics, Dr. Denneny highlighted other drugs that have had an impact on otolaryngology, including anesthetics such as propofol, which is used for outpatient procedures, and muscle relaxants such as succinylcholine. Otolaryngologists treating allergies may also have trouble accessing epinephrine and dexamethasone, he said, and those treating head and neck cancers may have difficulty obtaining chemotherapeutic drugs.

Causes and Solutions

According to the University of Utah Health Care, which partners with the American Society of Health-System Pharmacists (ASHP) to manage its drug shortage program, the reasons for drug shortages in 2014 included manufacturing problems (25%), supply and demand (17%), business decision/discontinued (9%), and raw material problems (2%). The most commonly cited reason, however, is unknown (47%).

One major challenge for otolaryngologists and other physicians is not knowing when a particular drug may be in short supply. “Physicians don’t know in advance that a drug is in short supply,” said Dr. Denneny, adding that they often only find out about a shortage after a patient has gone to the pharmacy to fill a prescription and the patient is told the drug is not available.

Pages: 1 2 3 4 | Single Page

Filed Under: Departments, Special Reports Tagged With: drugs, shortageIssue: October 2015

You Might Also Like:

  • National Drug Shortage Hits ENT Surgeries: Succinylcholine, propofol and tetracaine in limited supply
  • Rising Drug Costs Create Concern About Drug Diversions
  • Drug Selection Influences Drug-Induced Sleep Endoscopy Findings
  • When It Comes to Drug Development, What Do Our Dollars Buy?

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.